Where does Apyx Medical Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Apyx Medical Corporation ranks #23,887 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Apyx Medical Corporation hold?

Apyx Medical Corporation holds 11 US utility patents granted between 2020 and 2024, spanning 4 technology areas.

What is Apyx Medical Corporation's Innovation Score?

Apyx Medical Corporation has an Innovation Score of 39.8 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Apyx Medical Corporation focus on?

Apyx Medical Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Apyx Medical Corporation's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Apyx Medical Corporation.

What does claim depth mean for Apyx Medical Corporation's patents?

Apyx Medical Corporation's patents average 20.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Apyx Medical Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Apyx Medical Corporation

USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Apyx ranks #23,887 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.

#23,887
of 49,997 US assignees by volume: Top 37%
by Innovation Score (39.8/100): 20.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R23887 · US Corporation #23,887 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #23,887/49,997
PHOTO-FINISH Apogee Semiconductor
CPC-NARROW A61B · 4 areas
INNOV-THIN 39.8/100
CLAIMS-DENSE 20.8 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Apogee Semiconductor, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Apyx’s 39.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (22%) Velocity 11.7 pts (29%) Breadth 7.1 pts (18%) Claim depth 12.5 pts (31%)

Qualcomm Incorporated · highest

85
Apyx Medical · this assignee

40
3D Lighting… · lowest

7

What this shows Apyx's Innovation Score is 39.8/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Apyx?

Each dot is one of Apyx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Apyx’s own 20.8 claims/patent is ABOVE the 20.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Apyx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Apyx's grants concentrate

Apyx Medical Corporation is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2020. By volume, Apyx sits between Apogee Semiconductor, Inc. and ArjoHuntleigh Magog Inc..

Apyx's three-year grant acceleration

Apyx Medical Corporation shows 7 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Apogee Semiconduc…

11
Apollo Autonomous…

11
Appliance Computi…

11
Applied Spectra

11
Arbor Lllp

11
Arcellx

11
Arelac

11
Arjohuntleigh Mag…

11
Apyx Medical ◀

11

What this shows Apyx holds 11 patents at rank #23,921, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Apyx

By rank, the assignees closest to #23,921 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Apyx's primary technology class.

Apyx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Apyx Medical Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	9.1%
2021	3	27.3%
2022	1	9.1%
2023	3	27.3%
2024	3	27.3%

Which technologies does Apyx Medical Corporation patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

B23K - Soldering OR UNSOLDERING; WELDING; Cladding OR Plating BY Soldering OR WELDING; Cutting BY Applying Heat Locally, e.g. Flame CUTTING; Working BY Laser Beam 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Apyx Medical Corporation's patent record in context - here's where to go next.

Apyx Medical Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #23,887 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Apyx Medical Corporation against Apogee Semiconductor, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.